Oncobiologics and Aktis Oncology Directors Trade Shares

Director Faisal Ghiath Sukhtian of Oncobiologics, Inc. purchased 95,398 shares at an average price of $1.05 per share, a total transaction value of about $100,168. The purchase raised his holding to 220,972 shares valued at roughly $232,021.

Director Ken Herrmann of Aktis Oncology sold 4,856 shares at an average price of $24.56 per share, generating proceeds of approximately $119,263. After the sale, he retained 3,506 shares worth about $86,107.